798 related articles for article (PubMed ID: 24401287)
1. Proceedings from the Third National Institutes of Health International Congress on Advances in Uterine Leiomyoma Research: comprehensive review, conference summary and future recommendations.
Segars JH; Parrott EC; Nagel JD; Guo XC; Gao X; Birnbaum LS; Pinn VW; Dixon D
Hum Reprod Update; 2014; 20(3):309-33. PubMed ID: 24401287
[TBL] [Abstract][Full Text] [Related]
2. The management of uterine leiomyomas.
Vilos GA; Allaire C; Laberge PY; Leyland N;
J Obstet Gynaecol Can; 2015 Feb; 37(2):157-178. PubMed ID: 25767949
[TBL] [Abstract][Full Text] [Related]
3. The second National Institutes of Health International Congress on advances in uterine leiomyoma research: conference summary and future recommendations.
Dixon D; Parrott EC; Segars JH; Olden K; Pinn VW
Fertil Steril; 2006 Oct; 86(4):800-6. PubMed ID: 17027353
[TBL] [Abstract][Full Text] [Related]
4. The management of uterine fibroids in women with otherwise unexplained infertility.
Carranza-Mamane B; Havelock J; Hemmings R; ;
J Obstet Gynaecol Can; 2015 Mar; 37(3):277-285. PubMed ID: 26001875
[TBL] [Abstract][Full Text] [Related]
5. The management of uterine leiomyomas.
Lefebvre G; Vilos G; Allaire C; Jeffrey J; Arneja J; Birch C; Fortier M; Wagner MS;
J Obstet Gynaecol Can; 2003 May; 25(5):396-418; quiz 419-22. PubMed ID: 12738981
[TBL] [Abstract][Full Text] [Related]
6. Comprehensive Review of Uterine Fibroids: Developmental Origin, Pathogenesis, and Treatment.
Yang Q; Ciebiera M; Bariani MV; Ali M; Elkafas H; Boyer TG; Al-Hendy A
Endocr Rev; 2022 Jul; 43(4):678-719. PubMed ID: 34741454
[TBL] [Abstract][Full Text] [Related]
7. Modern management of uterine fibroids.
Levy BS
Acta Obstet Gynecol Scand; 2008; 87(8):812-23. PubMed ID: 18607823
[TBL] [Abstract][Full Text] [Related]
8. SOGC clinical practice guidelines. Uterine fibroid embolization (UFE). Number 150, October 2004.
Society of Obstetricians and Gynaecologists of Canada
Int J Gynaecol Obstet; 2005 Jun; 89(3):305-18. PubMed ID: 16001461
[TBL] [Abstract][Full Text] [Related]
9. Optimizing research in symptomatic uterine fibroids with development of a computable phenotype for use with electronic health records.
Hoffman SR; Vines AI; Halladay JR; Pfaff E; Schiff L; Westreich D; Sundaresan A; Johnson LS; Nicholson WK
Am J Obstet Gynecol; 2018 Jun; 218(6):610.e1-610.e7. PubMed ID: 29432754
[TBL] [Abstract][Full Text] [Related]
10. Epidemiology and management of uterine fibroids.
Giuliani E; As-Sanie S; Marsh EE
Int J Gynaecol Obstet; 2020 Apr; 149(1):3-9. PubMed ID: 31960950
[TBL] [Abstract][Full Text] [Related]
11. Uterine fibroid management: from the present to the future.
Donnez J; Dolmans MM
Hum Reprod Update; 2016 Nov; 22(6):665-686. PubMed ID: 27466209
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic management of uterine fibroid tumors: updated French guidelines.
Marret H; Fritel X; Ouldamer L; Bendifallah S; Brun JL; De Jesus I; Derrien J; Giraudet G; Kahn V; Koskas M; Legendre G; Lucot JP; Niro J; Panel P; Pelage JP; Fernandez H;
Eur J Obstet Gynecol Reprod Biol; 2012 Dec; 165(2):156-64. PubMed ID: 22939241
[TBL] [Abstract][Full Text] [Related]
13. EMAS position statement: management of uterine fibroids.
Pérez-López FR; Ornat L; Ceausu I; Depypere H; Erel CT; Lambrinoudaki I; Schenck-Gustafsson K; Simoncini T; Tremollieres F; Rees M;
Maturitas; 2014 Sep; 79(1):106-16. PubMed ID: 24975954
[TBL] [Abstract][Full Text] [Related]
14. Epidemiological and genetic clues for molecular mechanisms involved in uterine leiomyoma development and growth.
Commandeur AE; Styer AK; Teixeira JM
Hum Reprod Update; 2015; 21(5):593-615. PubMed ID: 26141720
[TBL] [Abstract][Full Text] [Related]
15. Uterine artery embolization for symptomatic uterine fibroids.
Gupta JK; Sinha A; Lumsden MA; Hickey M
Cochrane Database Syst Rev; 2014 Dec; (12):CD005073. PubMed ID: 25541260
[TBL] [Abstract][Full Text] [Related]
16. Advances in uterine leiomyoma research: conference overview, summary, and future research recommendations.
Newbold RR; DiAugustine RP; Risinger JI; Everitt JI; Walmer DK; Parrott EC; Dixon D
Environ Health Perspect; 2000 Oct; 108 Suppl 5():769-73. PubMed ID: 11035980
[TBL] [Abstract][Full Text] [Related]
17. Uterine artery embolization as a treatment option for uterine myomas.
Marshburn PB; Matthews ML; Hurst BS
Obstet Gynecol Clin North Am; 2006 Mar; 33(1):125-44. PubMed ID: 16504811
[TBL] [Abstract][Full Text] [Related]
18. Uterine fibroids: clinical manifestations and contemporary management.
Doherty L; Mutlu L; Sinclair D; Taylor H
Reprod Sci; 2014 Sep; 21(9):1067-92. PubMed ID: 24819877
[TBL] [Abstract][Full Text] [Related]
19. Management of uterine fibroids in the patient pursuing assisted reproductive technologies.
Ezzati M; Norian JM; Segars JH
Womens Health (Lond); 2009 Jul; 5(4):413-21. PubMed ID: 19586433
[TBL] [Abstract][Full Text] [Related]
20. Safety and efficacy of the selective progesterone receptor modulator asoprisnil for heavy menstrual bleeding with uterine fibroids: pooled analysis of two 12-month, placebo-controlled, randomized trials.
Stewart EA; Diamond MP; Williams ARW; Carr BR; Myers ER; Feldman RA; Elger W; Mattia-Goldberg C; Schwefel BM; Chwalisz K
Hum Reprod; 2019 Apr; 34(4):623-634. PubMed ID: 30865281
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
